GH financial statements
The full income statement, balance sheet, and cash-flow statement for Guardant Health Inc. (GH), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 982M+32.9% | 739M+31.0% | 564M+25.5% | 450M+20.3% | 374M+30.3% | |
| Cost of revenue | 349M+20.4% | 290M+27.6% | 227M | — | — | |
| Research & development | 364M+4.7% | 348M-5.3% | 367M-1.8% | 374M+42.0% | 263M+75.6% | |
| Selling, general & administrative | 211M+17.4% | 180M+15.6% | 156M-5.0% | 164M-20.7% | 207M+7.2% | |
| General & administrative | 211M+17.4% | 180M+15.6% | 156M-5.0% | 164M-20.7% | 207M+7.2% | |
| Selling & marketing | 495M+35.5% | 365M+23.6% | 295M-1.5% | 300M+56.3% | 192M+80.1% | |
| Amortization of intangibles | 1.70M-22.7% | 2.20M-18.5% | 2.70M+8.0% | 2.50M+31.6% | 1.90M+5.6% | |
| Operating income | -437M+1.4% | -444M+21.4% | -565M-3.7% | -544M-32.5% | -411M-61.2% | |
| Interest expense | 3.90M+51.0% | 2.58M+0.1% | 2.58M+0.0% | 2.58M+0.0% | 2.58M-45.9% | |
| Interest & investment income | 34.1M-36.5% | 53.7M+51.8% | 35.4M+482.7% | 6.07M+54.4% | 3.93M-61.4% | |
| Other non-operating income | -10.5M+75.4% | -42.6M-180.1% | 53.2M+516.1% | -12.8M-150.8% | 25.2M+591.5% | |
| Gain (loss) on equity securities | 0.00+100.0% | -44.4M-155.7% | 79.7M+1122.8% | -7.79M | 0.00 | |
| Pre-tax income | -418M+4.0% | -435M+9.1% | -479M+26.7% | -653M-70.0% | -384M-56.3% | |
| Income tax | -1.26M-198.4% | 1.28M+87.4% | 685K-39.9% | 1.14M+279.7% | 300K-20.8% | |
| -416M+4.6% | -436M+9.0% | -479M+26.8% | -655M-70.1% | -385M-56.2% | ||
| Net income to common | -416M+4.6% | -436M+9.0% | -479M+26.8% | -655M-61.4% | -406M-59.8% | |
| -$3.32+6.7% | -$3.56+16.8% | -$4.28+33.2% | -$6.41-60.3% | -$4.00-53.8% | ||
| EPS (basic) | -$3.32+6.7% | -$3.56+16.8% | -$4.28+33.2% | -$6.41-60.3% | -$4.00-53.8% | |
| Weighted-avg shares (basic) | 125M+2.1% | 123M+9.6% | 112M+9.6% | 102M+0.9% | 101M+3.9% | |
| Weighted-avg shares (diluted) | 125M+2.1% | 123M+9.6% | 112M+9.6% | 102M+0.9% | 101M+3.9% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 1.47B+38.9% | 1.06B-21.7% | 1.35B+13.1% | 1.19B+7.0% | 1.11B-41.0% | ||
| Cash & equivalents | 378M-28.0% | 526M-53.6% | 1.13B+700.3% | 142M-71.2% | 492M-40.9% | |
| Short-term investments | — | — | — | 870M+97.4% | 441M-54.2% | |
| Accounts receivable | 138M+25.0% | 110M+24.2% | 88.8M-8.7% | 97.3M-0.4% | 97.7M+83.2% | |
| Inventory | 85.9M+20.8% | 71.1M+14.7% | 61.9M+20.1% | 51.6M+68.2% | 30.7M+35.0% | |
| Prepaid expenses | 40.7M+20.5% | 33.8M+21.8% | 27.7M-12.0% | 31.5M-40.6% | 53.1M+203.7% | |
| 2.01B+35.5% | 1.49B-16.8% | 1.79B+11.0% | 1.61B-27.0% | 2.20B-3.0% | ||
| Property, plant & equipment | 146M+6.7% | 137M-5.7% | 145M-13.6% | 168M+34.9% | 124M+98.2% | |
| Operating lease right-of-use | 159M+11.7% | 142M-9.7% | 158M-9.4% | 174M-8.2% | 189M+407.3% | |
| Goodwill | 77.3M+2248.2% | 3.29M+0.0% | 3.29M+0.0% | 3.29M+0.0% | 3.29M+0.0% | |
| Intangible assets | 25.9M+283.4% | 6.76M-24.7% | 8.98M-23.4% | 11.7M-17.5% | 14.2M-12.1% | |
| Long-term investments | — | — | — | 0.00-100.0% | 698M+183.1% | |
| Other non-current assets | 28.5M-23.4% | 37.2M-70.1% | 124M+102.1% | 61.5M+0.8% | 60.9M+253.2% | |
| 303M+34.2% | 226M+9.6% | 206M+6.6% | 193M-0.8% | 195M+191.4% | ||
| Accounts payable | 54.4M+41.2% | 38.6M-25.5% | 51.7M-24.9% | 68.9M+78.9% | 38.5M+424.8% | |
| Accrued liabilities | 77.9M+14.0% | 68.3M+7.7% | 63.5M-63.9% | 176M+288.2% | 45.3M+100.0% | |
| Deferred revenue | 50.8M+43.1% | 35.5M+97.4% | 18.0M+3.2% | 17.4M+53.7% | 11.3M+32.5% | |
| Current lease liability | 27.7M-5.3% | 29.2M+4.5% | 27.9M+27.8% | 21.9M+70.2% | 12.9M+93.8% | |
| 2.11B+30.0% | 1.63B-0.2% | 1.63B+5.0% | 1.55B-0.6% | 1.56B+70.2% | ||
| Long-term debt | 1.50B+31.6% | 1.14B | — | — | — | |
| Deferred revenue (non-current) | 9.00M+47.5% | 6.10M+22.0% | 5.00M+31.6% | 3.80M | — | |
| Non-current lease liability | 178M+8.6% | 164M-11.6% | 186M-11.5% | 210M-7.1% | 226M+443.9% | |
| Operating lease liability (total) | 206M+6.5% | 194M-9.5% | 214M-7.8% | 232M-2.9% | 239M+395.7% | |
| Other non-current liabilities | 128M+37.6% | 92.8M-3.3% | 96.0M+945.9% | 9.18M+133.4% | 3.93M+158.8% | |
| -99.3M+28.9% | -140M-188.0% | 159M+163.7% | 60.2M-90.7% | 645M-50.3% | ||
| Additional paid-in capital | 2.90B+18.7% | 2.44B+6.1% | 2.30B+32.3% | 1.74B+5.1% | 1.66B-12.9% | |
| Retained earnings | -2.99B-16.1% | -2.58B-20.4% | -2.14B-28.8% | -1.66B-65.0% | -1.01B-66.1% | |
| Treasury stock | — | 0.00 | — | — | — | |
| Accumulated other comprehensive income | -4.85M+6.7% | -5.20M-41.5% | -3.67M+81.2% | -19.5M-309.8% | -4.76M-276.6% | |
| Total liabilities & equity | 2.01B+35.5% | 1.49B-16.8% | 1.79B+11.0% | 1.61B-27.0% | 2.20B-3.0% | |
| Common shares issued | 131M+5.4% | 124M+1.9% | 122M+18.5% | 103M+0.8% | 102M+1.6% | |
| Common shares outstanding | 131M+5.4% | 124M+1.9% | 122M+18.5% | 103M+0.8% | 102M+1.6% | |
| Shares outstanding (cover) | 131M+6.3% | 123M+1.4% | 122M+18.6% | 103M+0.8% | 102M+1.4% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| -185M+23.0% | -240M+26.2% | -325M-5.0% | -309M-48.1% | -209M-101.1% | ||
| Depreciation & amortization | 39.7M-6.3% | 42.4M-1.2% | 42.9M+19.2% | 36.0M+61.5% | 22.3M+38.6% | |
| Intangible amortization | 1.70M-22.7% | 2.20M-18.5% | 2.70M+8.0% | 2.50M+31.6% | 1.90M+5.6% | |
| Share-based compensation | 166M+18.4% | 140M+54.7% | 90.8M-4.1% | 94.7M-37.5% | 151M+5.1% | |
| Deferred income taxes | -1.71M-694.1% | 287K+153.0% | -541K-129.2% | -236K-232.6% | 178K+34.8% | |
| Change in receivables | 28.2M+31.7% | 21.4M+355.3% | -8.38M-2134.1% | -375K-100.8% | 44.4M+711.9% | |
| Change in inventory | 14.8M+61.9% | 9.13M-11.7% | 10.3M-50.5% | 20.9M+163.0% | 7.96M+5.6% | |
| Change in payables | — | — | — | — | 8.64M+209.9% | |
| -627M-140.0% | -261M-131.1% | 840M+460.9% | 150M+337.2% | -63.2M+89.8% | ||
| Capital expenditure | 48.3M+37.7% | 35.1M+71.3% | 20.5M-73.6% | 77.5M+3.2% | 75.0M+107.4% | |
| Free cash flow | -233M+15.2% | -275M+20.4% | -345M+10.7% | -387M-36.2% | -284M-102.7% | |
| Acquisitions | 59.0M | 0.00 | 0.00 | 0.00 | 0.00 | |
| Sales/maturities of investments | 307M+778.1% | 35.0M-97.7% | 1.49B+169.3% | 555M-41.7% | 952M | |
| Other investing activities | — | — | -1.53M | 0.00 | 0.00 | |
| 671M+67482.8% | -996K-100.2% | 477M+352.5% | -189M-183.0% | -66.8M-104.7% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 257M | 0.00-100.0% | 493M | 0.00 | 0.00-100.0% | |
| Common stock repurchased | 45.0M | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other financing activities | 3.60M+2450.3% | -153K-102.5% | 6.03M+630.6% | -1.14M-22.2% | -930K | |
| Net change in cash | -140M+72.2% | -504M-150.8% | 992M+383.1% | -350M-2.8% | -341M-149.4% | |
| Interest paid | 3.77M | 0.00 | 0.00 | — | 0.00 | |
| Income taxes paid | 869K-13.7% | 1.01M-48.9% | 1.97M+47.9% | 1.33M+238.7% | 393K+18.7% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 13.4B+255.3% | 3.77B+18.1% | 3.19B+14.6% | 2.79B-72.7% | 10.2B-21.3% | |
| P/S | 13.6×+167.4% | 5.1×-14.4% | 6.0×-7.9% | 6.5×-76.3% | 27.3×-39.6% | |
| P/B | — | — | 14.0×-16.3% | 16.7×+5.8% | 15.8×+58.5% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: GH’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all GH filings on SEC EDGAR → Not investment advice.
